Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novan Inc (NQ: NOVN ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Novan Inc < Previous 1 2 3 4 5 Next > Earnings Scheduled For March 30, 2023 March 30, 2023 Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. Via Benzinga Novan Reports Full Year 2022 Financial Results and Provides Corporate Update March 30, 2023 From Novan, Inc. Via GlobeNewswire Earnings Outlook For Novan March 29, 2023 Via Benzinga Novan to Report Full Year 2022 Financial Results on March 30, 2023 March 23, 2023 From Novan, Inc. Via GlobeNewswire Looking Into Novan's Return On Capital Employed December 23, 2022 Via Benzinga Novan Announces Closing of $6.0 Million Registered Direct Offering March 16, 2023 From Novan, Inc. Via GlobeNewswire Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference March 14, 2023 Presentation with live webcast today, March 14th at 10:40 AM ET From Novan, Inc. Via GlobeNewswire Novan Announces $6.0 Million Registered Direct Offering March 14, 2023 From Novan, Inc. Via GlobeNewswire Novan Moves Forward with Unified Corporate Branding March 08, 2023 From Novan, Inc. Via GlobeNewswire FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024 March 07, 2023 From Novan, Inc. Via GlobeNewswire Novan to Present at the Virtual Investor 2023 Companies to Watch Event January 18, 2023 Live video webcast on Thursday, January 19th at 12:00 PM ET From Novan, Inc. Via GlobeNewswire JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th January 11, 2023 Via ACCESSWIRE Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum January 06, 2023 From Novan, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 22, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 21, 2022 Via Benzinga EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan December 21, 2022 From Novan, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session December 05, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session December 02, 2022 Via Benzinga EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement December 02, 2022 From Novan, Inc. Via GlobeNewswire Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference December 01, 2022 From Novan, Inc. Via GlobeNewswire Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 From Novan, Inc. Via GlobeNewswire Novan to Report Third Quarter 2022 Financial Results on November 14, 2022 November 07, 2022 From Novan, Inc. Via GlobeNewswire EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 Research shows PAD (Polyaphron Dispersion) Technology™ leads to more efficient delivery of Calcipotriene (CAL) and Betamethasone Dipropionate (BDP) than CAL/BDP topical suspension From Novan, Inc. Via GlobeNewswire Earnings Scheduled For November 14, 2022 November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. Via Benzinga EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 Data collected shows importance of treatment formulation characteristics and speed of improvement in psoriasis symptoms to patient treatment adherence From Novan, Inc. Via GlobeNewswire Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference® October 14, 2022 From Novan, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session October 10, 2022 Gainers Via Benzinga Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday October 11, 2022 Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued... Via Benzinga Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session October 10, 2022 Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday October 05, 2022 Wednesday saw 127 companies set new 52-week lows. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.